Clinical Trial

Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis

Study acronym: MFR/KNEE OA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to determine whether gastrocnemius myofascial release is effective in reducing pain and improving physical function in females with knee osteoarthritis. The main question this study aims to answer are: * Does adding gastrocnemius MFR to conventional physical therapy treatment influence pain, physical function, foot posture, and knee disability compared to conventional physical therapy treatment and sham MFR in knee osteoarthritis? * Participants receive gastrocnemius myofascial release treatment or sham gastrocnemius myofascial release treatment for 3 times weekly for 4 weeks for both groups.
Trial Details
NCT Number NCT07507175
Lead Sponsor Cairo University
Conditions Knee Osteoarthritis
Enrollment 30 participants
Start Date 2026-01-03
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-02